| 3.58 -0.25 (-6.53%) | 07-26 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 4.45 |
1-year : | 5.24 |
| Resists | First : | 3.81 |
Second : | 4.48 |
| Pivot price | 3.85 |
|||
| Supports | First : | 2.71 |
Second : | 2.25 |
| MAs | MA(5) : | 3.86 |
MA(20) : | 3.74 |
| MA(100) : | 2.4  |
MA(250) : | 1.72 |
|
| MACD | MACD : | 0.2 |
Signal : | 0.2 |
| %K %D | K(14,3) : | 49.9 |
D(3) : | 67 |
| RSI | RSI(14): 50.5 |
|||
| 52-week | High : | 4.48 | Low : | 0.54 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ EUDA ] has closed below the lower bollinger band by 1.1%. Bollinger Bands are 25.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 3.94 - 3.97 | 3.97 - 4 |
| Low: | 3.44 - 3.48 | 3.48 - 3.51 |
| Close: | 3.53 - 3.6 | 3.6 - 3.65 |
EUDA Health Limited develops digital health platform that offers virtual consults for non-emergency medical issues. The company was founded in 2019 and is based in Singapore. EUDA Health Limited company operates as a subsidiary of Watermark Developments Limited.
Sat, 01 Jun 2024
symbol__ Stock Quote Price and Forecast - CNN
Mon, 13 May 2024
FAST NEWS: Euda Health acquires CK Health in $15 million deal - Bamboo Works
Wed, 08 May 2024
EUDA Health completes acquisition of CK Health Plus Sdn Bhd - TipRanks
Mon, 06 May 2024
EUDA Health expands into wellness products with $15M acquisition of CK Health - Seeking Alpha
Fri, 06 Oct 2023
FAST NEWS: EUDA Health to merge with developer of cancer, women’s health treatments - Bamboo Works
Fri, 10 Mar 2023
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.07% - Investing.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Information Services
|
|
| Shares Out | 35 (M) |
| Shares Float | 12 (M) |
| Held by Insiders | 49.3 (%) |
| Held by Institutions | 2.7 (%) |
| Shares Short | 21 (K) |
| Shares Short P.Month | 24 (K) |
| EPS | -0.38 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -0.31 |
| Profit Margin | -270.9 % |
| Operating Margin | -106.9 % |
| Return on Assets (ttm) | -18.4 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0.1 |
| EBITDA (p.s.) | -0.12 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -3 (M) |
| Levered Free Cash Flow | 2 (M) |
| PE Ratio | -9.68 |
| PEG Ratio | 0 |
| Price to Book value | -11.94 |
| Price to Sales | 33.89 |
| Price to Cash Flow | -43.08 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|